Novavax Inc (NVAX) — Analysis Summary
Novavax Inc (NVAX) has a market cap of $1.80B with year-over-year revenue growth of +64.7%. Net margin stands at 39.2%. The stock trades at a P/E ratio of -20.5.
Key Takeaways
- Revenue changed +64.7% year-over-year
- Net margin of 39.2%
- P/E ratio of -20.5
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, NVAX posted revenue growth of +64.7% and trades at a P/E of -20.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.